<i>FLNC</i> and <i>MYLK2</i> Gene Mutations in a Chinese Family with Different Phenotypes of Cardiomyopathy-Reference-Cited by-同舟云学术

FLNC and MYLK2 Gene Mutations in a Chinese Family with Different Phenotypes of Cardiomyopathy

Published:2021-01-30 Issue:1 Volume:62 Page:127-134
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Qin Xianyu¹,Li Ping²,Qu Hui-Qi³,Liu Yichuan³,Xia Yu¹,Chen Shaoxian¹,Yang Yongchao¹,Huang Shufang³,Wen Pengju¹,Zhou Xianwu¹,Li Xiaofeng¹,Wang Yonghua²,Tian Lifeng³,Hakonarson Hakon³⁴,Wu Yueheng¹,Zhuang Jian¹

Affiliation:

1. Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences

2. Prenatal Diagnosis Center, Department of Obstetrics and Gynecology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences

3. Center for Applied Genomics, The Children's Hospital of Philadelphia

4. Department of Pediatrics and Division of Human Genetics, University of Pennsylvania

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/62/1/62_20-351/_pdf

Reference30 articles.

1. 1. Ingles J, Semsarian C. Family matters: outcomes of hypertrophic cardiomyopathy family screening. Circ Genom Precis Med 2018; 11: e002112.

2. 2. Biswas A, Das S, Kapoor M, et al. Familial hypertrophic cardiomyopathy - Identification of cause and risk stratification through exome sequencing. Gene 2018; 660: 151-6.

3. 3. Ko C, Arscott P, Concannon M, et al. Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup. Genet Med 2018; 20: 69-75.

4. 4. Elliott PM, Anastasakis A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J Elliott: Task Force, PM, A. Anastasakis, M.A. Borger, M. Borggrefe, F. Cecchi, P. Charron, A.A. Hagege, A. Lafont, G. Limongelli, H. Mahrholdt, W.J. McKenna, J. Mogensen, P. Nihoyannopoulos, S. Nistri, P.G. Pieper, B. Pieske, C. Rapezzi, F.H. Rutten, C. Tillmanns, H. Watkins 2014; 35: 2733-79.

5. 5. Valdés-Mas R, Gutiérrez-Fernández A, Gómez J, et al. Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy. Nat Commun 2014; 5: 5326.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Spectrum of Minor Genes in Cardiomyopathies: A Narrative Review;International Journal of Molecular Sciences;2024-09-10

2. Identification of novel prognostic targets in acute kidney injury using bioinformatics and next generation sequencing data analysis;2024-03-17

3. Comparison of differentially expressed genes in longissimus dorsi muscle of Diannan small ears, Wujin and landrace pigs using RNA-seq;Frontiers in Veterinary Science;2024-01-05

4. Pathogenetics of Cardiomyopathy;Russian Journal of Genetics;2023-06

5. Pathogenetics of Cardiomyopathy;Генетика;2023-06-01